TruBridge Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $345.9M+1.1% YoYTTM through 31 Mar 2026
Net Income $4.4MTTM through 31 Mar 2026
Free Cash Flow $44.6MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 53.0% |
| EBITDA Margin | 8.4% |
| Operating Margin | 6.0% |
| Net Margin | 1.3% |
Returns
2.5%ROE
1.1%ROA
1.4%ROIC
Balance Sheet Health
Debt / Equity0.94x
Current Ratio1.78x
Net Debt$139.8M
Cash & Equivalents$35.4M
Quality Metrics
Altman Z-Score2.11
Piotroski F-Score5 / 9
FCF Margin12.9%
Rule of 4015.5
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $346.8M
Diluted EPS$0.29TTMFY2025: $0.29
Dividend
No dividend
Capital Allocation
R&D Spend$31.8M
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Financial Health | $221.7M | +2.0% | View detailsExpected to scale enterprise analytics and operationalize high-impact AI use cases. |
| Patient Care | $125.2M | 0.0% | View detailsImpacted by the sunset of the Centriq platform, but seeing growth in SaaS bookings. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.